|
[1]Miwa Y, Harrison PM, Farzaneh F, et al.Plasma levels and hepaticmRNA expression of transforming growth factor betal in patients withfulminant hepatic failure[J].J Hepatol, 1997, 27∶780.
|
|
[2]Michalopounlos SK, Defrances MC.Liver regeneration[J].Science, 1997, 276∶60.
|
|
[3]Taub R.Liver egeneration4:transcriptional control of liver regenera-tion[J].Faseb J, 1996, 10∶413.
|
|
[4]Mizuguchi T, Kamohara Y, Hui T, et al.Regulation of c-met ex-pression in rats with acute hepatic failure[J].J Surg Res, 2001, 99 (2) ∶385-396.
|
|
[5]Chang B, Nishikawa M, Sato E, et al.Mice lacking inducible nitricoxide synthase show stronge resistance to anti-Fas antibody-in-duced fulminant hepatitis[J].Arch Biochem Biophys, 2003, 411∶63-72.
|
|
[6]Moriuchi A, Hirono S, Ido A, et al.Additive and inhibitory effectsof-simulaneous treatment with growth factors on DNA synthesisthrough MAPK pathway and G1 cyclins in rats hepatocytes[J].Bio-chem Biophs Res Commun, 2001, 280 (1) ∶368-373.
|
|
[7]Stephen M, Riordan, Roger W.Acuter liver failure:rargeted artifi-cial and hepatocyte-based support of liver regeneration and reversalof multiorgen failure[J].Hepatol, 2000, 32 (supple) ∶63.
|
|
[8]Streetz K, Leifeld L, Grundmann D, et al.Tumor necrosis factor al-pha in the pathogenesis of human and murine fulminant hepatic fail-ure[J].Gastroenterology, 2000, 119∶446-460.
|
|
[9]Nagaki M, Iwai H, Naiki T, et al.High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality infulminant hepatitis[J].J Infect Dis, 2000, 182∶1103-1108.
|
|
[10]Ross R.Platelet-derived growth factor[J].Lancet, 1989, 1 (8648) ∶1179-1182.
|
|
[11]Mizuguchi T, Kamohara Y, Hui T, et al.Regulation of c-met ex-pression in rats with acute hepatic failure[J].J Surg Res, 2001, 99 (2) ∶385-396.
|
|
[12]Suh KS, Lilja H, Kamohara Y, et al.Bioartificial liver treatment inrats with fulminant hepatic failure:effect on DNA-binding activityof liver-enriched and growth-associated transcription factors[J].JSurg Res, 1999, 85 (2) ∶243-250.
|
|
[13]Schzlch DS, Kalayolu M, Pirsch JD, et al.Serum insulin-likegrowth factors and their binding proteins in patients with hepatic fail-ure and after liver transplantation[J].Metablism, 1998, 47 (2) ∶200-206.
|
|
[14]Grun R, Jacyna S, Thomas H, et al.Growth hormone in the fe-males with liver cirrhosis[J].Gastroenterol, 1989, 27 (6) ∶33.
|
|
[15]Stwart CEH, Rotwein P.Growth differentiation and survival:multi-ple physiological functions for insulin-like growth factors[J].Physi-ol Rev, 1996, 76 (10) ∶1005.
|
|
[16]吴云林, 叶静, 张曙, 等.肝硬化患者血清胰岛素样生长因子及其结合蛋白测定与肝功能状况的关系[J].中华消化杂志, 2002, 22 (10) ∶601-604.
|
|
[17]Tsai JF, Jeng JE, Chuang LY, et al.Serum insulin-like growthfactor-Ⅱas a serologic marker of small hepatocellularcarcinoma[J].Scand J Gastroenterol, 2005, 40∶68-75.
|
PDF下载 ( 212 KB)
本文二维码
下载:
